SCHEMBL7681396

SCHEMBL7681396

NC(=O)C(Cc1ccccc1O)CC(O)[CH]Cc1ccccc1

nearest known ligand 0.38

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
AKR1B1 P15121 1/20 0.37
EPHX1 P07099 1/20 0.36
SLC7A5 Q01650 1/20 0.35
SLC1A3 P43003 1/20 0.35
SLC1A2 P43004 1/20 0.35
SLC1A1 P43005 1/20 0.35
POLB P06746 2/20 0.35
MAPK1 P28482 1/20 0.35
ALDH1A1 P00352 1/20 0.35
L3MBTL1 Q9Y468 1/20 0.35
CYP1A2 P05177 1/20 0.34
TRPA1 O75762 1/20 0.34
IL1RN P18510 2/20 0.34
ERAP2 Q6P179 2/20 0.34
ERAP1 Q9NZ08 2/20 0.34
CCR1 P32246 1/20 0.34
TRPV1 Q8NER1 1/20 0.33
PKM P14618 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4063724 0.89 BID (0.36) AKR1B1EPHX1SLC1A3SLC1A2SLC1A1
SCHEMBL4062969 0.86 ADRA1D (0.36) EPHX1SLC1A3SLC1A2SLC1A1POLB
SCHEMBL4070562 0.86 PLA2G10 (0.39) SLC7A5
SCHEMBL4061937 0.84 HMGB1 (0.34) EPHX1SLC1A3SLC1A2SLC1A1POLB
SCHEMBL7679450 0.83 TRPV1 (0.48) EPHX1SLC7A5SLC1A3SLC1A2SLC1A1
SCHEMBL4070172 0.81 KMT2A (0.33) EPHX1SLC1A3SLC1A2SLC1A1POLB
SCHEMBL4064377 0.81 ADRA1D (0.35) EPHX1POLBALDH1A1L3MBTL1
SCHEMBL4064865 0.81 TDP1 (0.38) EPHX1SLC1A3SLC1A2SLC1A1POLB
SCHEMBL4063820 0.81 KDM4E (0.37) ALDH1A1CYP1A2TRPV1
SCHEMBL7685992 0.81 GRIA2 (0.41) SLC1A3SLC1A2SLC1A1CYP1A2ERAP2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6403587-B1 AUTOIMMUNE DISEASES, ACUTE AND CHRONIC INFLAMMATORY CONDITIONS, ALLERGIC CONDITIONS, INFECTION ASSOCIATED WITH INFLAMMATION, VIRAL, TRANSPLANTATION TISSUE REJECTION, ATHEROSCLEROSIS, RESTENOSIS, HIV INFECTIVITY, AND PFIZER INC. 2002-06-11 US disclosed